Glovax to start P7.5bn vaccine plant operations in October 2022

Glovax to start P7.5bn vaccine plant operations in October 2022

The Department of Trade and Industry (DTI) and Glovax Biotech Corp. signed a memorandum of agreement with the Department of Trade and Industry (DTI) regarding the P7.5 billion-COVID-19 vaccine plant project in the country.

Glovax is looking to start the facility operations in October 2022. It will fill vials with COVID-19 vaccines developed by its South Korean technology partner EuBiologics Co. Ltd.

The Anti-Red Tape Authority, Department of Health, Food and Drug Administration, Department of Trade and Industry-Board of Investments, Department of Science and Technology, and National Task Force Against COVID-19 has recently signed a joint memorandum circular providing a green lane for COVID-19 manufacturers in the country.

United Laboratories Inc., IG/IP Biotech and Dr. Zen Biotech has previously expressed interest in putting up vaccine manufacturing plants in the country.

Read more here. 

Shares